Gang Yang - China Biologic VP
VP
Mr. Gang Yang is Corporationrationrate Vice President, General Manager of Guizhou Taibang, owned subsidiary of China Biologic Products, Inc., since August 2013. Prior to that, he held various management positions at Guizhou Taibang, including being the Deputy General Manager. Mr. Yang has more than 20 years of experience in Chinas plasma industry, holding various senior operation, production and plasma resource management positions with various plasma production organizations. Prior to joining us, Mr. Yang was a director of Guizhou Qianfeng Biologic Products Company. since 2013.
| Age | 51 |
| Tenure | 11 years |
| Phone | (86) 10 6598 3222 |
| Web | www.chinabiologic.com |
China Biologic Management Efficiency
The company has return on total asset (ROA) of 5.82 % which means that it generated a profit of $5.82 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on stockholder's equity (ROE) of 9.25 %, meaning that it created $9.25 on every $100 dollars invested by stockholders. China Biologic's management efficiency ratios could be used to measure how well China Biologic manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 1 records | VP Age | ||
| Robert Bond | Parker Hannifin | 57 | |
Management Performance
| Return On Equity | 9.25 | |||
| Return On Asset | 5.82 |
China Biologic Products Leadership Team
Elected by the shareholders, the China Biologic's board of directors comprises two types of representatives: China Biologic inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Biologic's management team and ensure that shareholders' interests are well served. China Biologic's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Biologic's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Min Fang, Director | ||
| Zhijing Liu, Corporate VP | ||
| Ming Yang, CFO | ||
| Joseph Chow, Independent Director | ||
| Gang Yang, Corporate VP and General Manager of Guizhou Taibang | ||
| Xiaosheng Shao, Independent Director | ||
| Ming Yin, Sr. Corporate VP and Corporate Secretary | ||
| Zhijun Tong, Independent Director | ||
| Yungang Lu, Independent Director | ||
| Wenfang Liu, Independent Director | ||
| Wai Yeung, Independent Director | ||
| David Li, Director | ||
| David Gao, Chairman of the Board and Presidentident, CEO | ||
| Xiaoying Gao, Executive Chairman, CEO and Pres |
China Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is China Biologic a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 9.25 | |||
| Return On Asset | 5.82 | |||
| Profit Margin | 29.04 % | |||
| Operating Margin | 37.26 % | |||
| Current Valuation | 3.56 B | |||
| Shares Outstanding | 38.79 M | |||
| Shares Owned By Insiders | 45.08 % | |||
| Shares Owned By Institutions | 51.03 % | |||
| Number Of Shares Shorted | 781.13 K | |||
| Price To Earning | 31.41 X |
Pair Trading with China Biologic
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if China Biologic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Biologic will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to ConocoPhillips could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ConocoPhillips when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ConocoPhillips - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ConocoPhillips to buy it.
The correlation of ConocoPhillips is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ConocoPhillips moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ConocoPhillips moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ConocoPhillips can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in China Stock
If you are still planning to invest in China Biologic Products check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Biologic's history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |